Literature DB >> 11908861

Tumor lysis syndrome after hydrocortisone treatment in metastatic melanoma: a case report and review of the literature.

George S Habib1, Walid R Saliba.   

Abstract

Tumor lysis syndrome (TLS) is 1 of the complications that usually follows chemotherapy treatment of myelo-lymphoproliferative diseases. Corticosteroids (CS) could also induce TLS in this type of malignancies. On the other hand, TLS in solid tumors is less frequent, and CS treatment was never reported to be associated with TLS in solid tumor. Here we report the first case of TLS in a solid tumor (melanoma) after CS treatment.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11908861     DOI： 10.1097/00000441-200203000-00007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


  11 in total

Review 1.  Spontaneous tumour lysis syndrome.

Authors:  Natasha Kekre; Bojana Djordjevic; Claire Touchie
Journal:  CMAJ       Date:  2012-04-10       Impact factor: 8.262

2.  Tumor lysis syndrome and metastatic melanoma.

Authors:  Marshall W Meeks; Muhammad B Hammami; Katherine J Robbins; Kevin L Cheng; Jack M Lionberger
Journal:  Med Oncol       Date:  2016-11-02       Impact factor: 3.064

3.  Tumor lysis syndrome and malignant melanoma.

Authors:  Meir Mouallem; Noa Zemer-Wassercug; Eitan Kugler; Nadav Sahar; Ronnie Shapira-Frommer; Ginette Schiby
Journal:  Med Oncol       Date:  2013-05-15       Impact factor: 3.064

Review 4.  Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies.

Authors:  Ali McBride; Peter Westervelt
Journal:  J Hematol Oncol       Date:  2012-12-13       Impact factor: 17.388

5.  An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review.

Authors:  Danica Maria Vodopivec; Jose Enrique Rubio; Alessia Fornoni; Oliver Lenz
Journal:  Case Rep Med       Date:  2012-05-27

6.  Acute hepatic failure and multi-system organ failure secondary to replacement of the liver with metastatic melanoma.

Authors:  Gilaad G Kaplan; Shaun Medlicott; Bruce Culleton; Kevin B Laupland
Journal:  BMC Cancer       Date:  2005-06-30       Impact factor: 4.430

7.  Spontaneous Tumor Lysis Syndrome in Metastatic Melanoma.

Authors:  Mingchen Song; Chris C W Chan; David A Stoeckel
Journal:  World J Oncol       Date:  2011-08-24

8.  Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase).

Authors:  Andrea Pession; Fraia Melchionda; Claudia Castellini
Journal:  Biologics       Date:  2008-03

Review 9.  Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.

Authors:  Bruce D Keith
Journal:  BMC Cancer       Date:  2008-03-28       Impact factor: 4.430

Review 10.  Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Maliha Khan; Aram Barbaryan
Journal:  Rare Tumors       Date:  2014-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.